Home › Trial NCT05437692
Zimberelimab Combined With Concurrent Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
- Trial IDNCT05437692
- StatusUnknown
- PhasePhase 2
- Study typeInterventional
- SponsorShanghai Zhongshan Hospital
- Enrollment19
- Start date2022-07-15
- ConditionsLocally Advanced Cervical Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.